Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2013; 19(1): 57-64
Published online Jan 7, 2013. doi: 10.3748/wjg.v19.i1.57
Published online Jan 7, 2013. doi: 10.3748/wjg.v19.i1.57
Table 1 Characteristics of the study sample, distribution of steatosis as predicted by different methods, and comparison between subjects with fatty liver index ≥ 60 and < 60
Characteristics/method | Range | Total (n = 338) | FLI < 60 (n = 259) | FLI≥60 (n = 79) | P value |
Age (yr) | 50.8 ± 10.4 | 50.0 ± 10.4 | 53.3 ± 10.0 | 0.01 | |
Male % | 53.0 | 48.3 | 68.4 | 0.002 | |
BMI (kg/m2) | 27.2 ± 4.4 | 25.6 ± 3.2 | 32.4 ± 3.9 | < 0.001 | |
ALT (U/L) | 5-39 | 22.1 ± 9.6 | 20.6 ± 7.4 | 26.9 ± 13.5 | < 0.001 |
AST (U/L) | 5-40 | 23.0 ± 5.5 | 22.5 ± 4.8 | 24.7 ± 7.0 | 0.008 |
GGT (U/L) | 6-28 | 16.0 ± 12.1 | 13.9 ± 11.1 | 22.7 ± 12.7 | < 0.001 |
Glucose (mg/dL) | 70-110 | 90.8 ± 19.8 | 87.6 ± 16.2 | 101.0 ± 26.1 | < 0.001 |
Insulin (μU/mL) | 5-25 | 22.3 ± 11.7 | 19.5 ± 10.0 | 31.5 ± 12.3 | < 0.001 |
Triglycerides (mg/dL) | 50-175 | 116.8 ± 60.4 | 100.2 ± 44.4 | 170.9 ± 73.3 | < 0.001 |
Ferritin (ng/mL) | 7.1-151 | 72.7 ± 60.1 | 64.6 ± 55.3 | 100.1 ± 67.5 | < 0.001 |
FL on AUS % (n = 338) | 31.1 | 18.5 | 72.2 | < 0.001 | |
HRI (n = 331) | 1.3 ± 0.4 | 1.2 ± 0.3 | 1.6 ± 0.4 | < 0.001 | |
HRI ≥ 1.50 (FL) % | 24.2 | 13.9 | 57.0 | < 0.001 | |
SteatoTest (n = 338) | 0.3 ± 0.2 | 0.2 ± 0.1 | 0.6 ± 0.1 | < 0.001 | |
S ≥ 2 (FL) % | 20.4 | 3.9 | 74.7 | < 0.001 | |
S0 % | 66.9 | 84.2 | 10.1 | < 0.001 | |
S1 % | 1-5 | 12.7 | 12.0 | 15.2 | 0.45 |
S2 % | 6-33 | 13.0 | 3.9 | 43.0 | < 0.001 |
S3-S4 % | 34-100 | 7.4 | 0 | 31.6 | < 0.001 |
FLI (n = 338) | 36.7 ± 27.7 | 24.2 ± 17.1 | 77.8 ± 11.1 | < 0.001 | |
FLI ≥ 60 (FL) % | 23.4 | NA | NA | NA | |
FLI < 30 % | 48.8 | NA | NA | NA |
Table 2 Diagnostic value of fatty liver index for predicting steatosis vs SteatoTest or hepatorenal ultrasound index or abdominal ultrasound
FLI≥60 vs | Sensitivity % | Specificity % | PPV % | NPV % | κ |
SteatoTest ≥ S2 (n = 338) | 85.5 | 92.6 | 74.7 | 96.1 | 0.74 |
HRI ≥ 1.50 (n = 331) | 56.3 | 86.5 | 57 | 86.1 | 0.43 |
Abdominal ultrasound fatty liver (n = 244) | 80.3 | 87.3 | 72.2 | 91.5 | 0.65 |
- Citation: Zelber-Sagi S, Webb M, Assy N, Blendis L, Yeshua H, Leshno M, Ratziu V, Halpern Z, Oren R, Santo E. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World J Gastroenterol 2013; 19(1): 57-64
- URL: https://www.wjgnet.com/1007-9327/full/v19/i1/57.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i1.57